No, vit C infusions don’t improve survival in PDAC. Difference in OS has little to do with Vit C and likely due to imbalances between arms.. Reviewers please do your job and ask authors to highlight study limitations before publishing some like this. https://t.co/22NIgVFNjP
The Olive Lab is looking for a postdoc to lead our translational program on RAS inhibition in pancreatic cancer. Should have exceptional scientific and project management skills, and experience with transdisciplinary research. Must be a good human. https://t.co/N5MlpowaKi
The Kinsey Lab is looking for a talented Postdoctoral Fellow to join the lab! Experience in mouse tumor models, autophagy, and pre-clinical therapeutics a plus, but not necessary. Apply to [email protected]. #autophagy#PDA#RAS
Excited to finally share this review written with @ConanKinsey and @MaxTheSFCat on the utility mouse models in catapulting the progress of therapeutic development, especially in lung cancer, from the last 10 years. #endcancer#LCSM
https://t.co/QRF3DJfWUF
In the spring of 1998, Marisa Harris was diagnosed with stage IV pancreatic cancer.
It is 25 years since her diagnosis and five years since she shared her story with us. We decided to check in with Marisa for her insights into her life after PC. https://t.co/pcIFSaAA0y
So proud of Isabella Scalise presenting her work at Huntsman Cancer Institute at the ACCESS Scholars Symposium! She was mentored by Sophia Schuman while in the lab. @huntsmancancer@ssshoeman@UUtah#PancreaticCancer
Alec C. Kimmelman, Tor Erik Rusten, @Rushika_Perera, Phaedra C. Ghazi, and Wout Magits, explored Metabolism during the morning plenary session at #AACRras23. @rustenlab
Pleased to share our new preprint re a multicellular paracrine cascade that drives angiosuppression in PDAC. We also present an investigational framework for studying complex in vivo phenotypes using tumor explants, systems biology, GEM models, and molbio.https://t.co/hH35NEcDsV
For #FossilFriday, we have Kyla Beguesse from @naturalsciences studying prehistoric bone pathologies to determine causes of death across dinosaur taxa.
Working under @ExpeditionLive, we're excited to have Kyla looking closely at these incredible fossils!
#BLMPaleo#GSENM
Selected 📄 for our 7th #CME is “MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition” (https://t.co/kG7yADa61w).
New #CME activity @MSKCME is available here 👉 https://t.co/6g4qjvCsqb
At JEM, we strive to provide clear, detailed decisions that illustrate what is expected in revisions. Just ask Masahiro Yamamoto! Take the steps to transfer your paper for consideration by JEM editors 👉 https://t.co/kN1bGjcK20
Our 7th #CME activity @MSKCME is now available! 📄 “MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition” by the labs of @conankinsey & @MaxTheSFCat (https://t.co/kG7yADa61w).
To begin the activity, visit 👉 https://t.co/6g4qjvCsqb
Excited to share that my first (co-)first author was published today! Congrats to the team especially my dedicated mentors @ConanKinsey@MaxTheSFCat I’m so grateful to be a part of @huntsmancancer where we can do translational work like this to continue our fight against cancer!
Our 7th #CME activity with @MSKCME is now available!
👉 https://t.co/6g4qjvCsqb
📄 With a new content: “MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition” from the labs of @conankinsey & @MaxTheSFCat: https://t.co/kG7yADa61w